Articles related to Hepatology

This analysis of a PBC patient’s complex lipid profile underscores the importance of diagnosing the specific types of xanthomas, as they are directly indicative of underlying dyslipidemias, which require tailored therapeutic approaches.

In the evolving landscape of liver disease management, timely diagnosis and tailored treatment strategies for ascites and spontaneous bacterial peritonitis stand as pivotal elements in enhancing patient survival and quality of life, underscoring the necessity of adherence to updated guidelines.

Join a confluence of experts at the Mayo Clinic Innovations in Gastroenterology and Hepatology 2024, where the latest advancements in AI, digital tools, and endoscopic technology promise to redefine patient care in gastroenterology and hepatology.

Better Therapeutics’ digital therapeutic app has been recognized with FDA breakthrough device status, showcasing its potential in significantly reducing liver fat in patients with advanced liver disease through cognitive behavioral therapy.

For patients with cirrhosis facing venous thromboembolic events, the choice of anticoagulant—be it DOACs or LMWH—demands careful consideration of their unique hemostatic profile, emphasizing the need for personalized treatment strategies.

In this Phase 3 trial, resmetirom demonstrated a notable capacity to induce NASH resolution and improve liver fibrosis, offering hope for a therapeutic breakthrough in a field with limited treatment options. This study emphasizes the importance of advancing research in liver-directed therapies for NASH.